🇺🇸 FDA
Pipeline program

Avacincaptad pegol, FLUORESCEIN

ISEE2009

Phase 3 small_molecule active

Quick answer

Avacincaptad pegol, FLUORESCEIN for geographic atrophy is a Phase 3 program (small_molecule) at Astellas Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Astellas Pharma GmbH
Indication
geographic atrophy
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials